| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10964501 | Vaccine | 2015 | 7 Pages |
Abstract
High levels of pneumococcal serotype-specific antibodies were observed in the previous PPV23 vaccinated group, and more pronounced in the previous PCV13 group, and our data suggests that PCV13 is immunogenic for serotypes 1, 3, 4, 5, 7F, 18C, 19A, 19F and 23F, if used as a booster dose in asplenic patients with previous PPV23 vaccination.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Per Nived, Charlotte Sværke Jørgensen, Bo Settergren,